::. Institutional Biosafety CommitteeThe NIH Institutional Biosafety Committee (IBC) provides recommendations for safety policy to the Safety and Health Council for approval by the Director, NIH, or designee, in matters pertaining to the control of hazards associated with the intramural use of microbiological agents and their vectors and serves as an advisory body to the Division of Occupational Health and Safety (DOHS), Office of Research Services (ORS). Read more from the Charter for the NIH Institutional Biosafety Committee Membership Roster Dr. Maribeth V. Eiden, Chairperson Ms. Judith DiPietro Dr. Robert F. Hoyt Dr. Jonathan Silver Dr. Jonathan Vogel Dr. Robert Craigie Ms. Jennie Forehand Dr. Robert Seder Dr. Jospeph O’Malley Mr. Carl Seils Susan R. Farrer Dr. Deborah E. Wilson Adam Clarkson, NIH-IBC Executive Secretary |